IMM_Update_2013_March 1 |
Previous | 1 of 1 | Next |
|
small (250x250 max)
medium (500x500 max)
Large
Extra Large
large ( > 500x500)
Full Resolution
All (PDF)
|
This page
All
|
Oklahoma Immunization Update March 2013 PREVENTION and PREPAREDNESS SERVICES IMMUNIZATION SERVICE PLEASE POST & DISTRIBUTE TO ALL NURSING AND MEDICAL STAFF Oklahoma Clinics Achieve High Immunization Levels The Oklahoma State Department of Health Immunization Service would like to recognize the following clinics for their efforts to increase the immunization levels of children 19 through 35 months of age who have received the primary series of 4 DTaP, 3 polio, 1 MMR, 3 Hib, 3 HepB and 1 varicella: · Indian Health Care Resource Center, Tulsa - 80% · Warren Clinic Owasso - 100% · Dr. Thomas Salyer, D.O., Idabel – 84% The Indian Health Care Resource Center in Tulsa increased their immunization rate from 64% in 2010 to 80% for the first quarter of 2013. This increase was the result of clinic staff calling the parents of children who were behind on their immunizations and scheduling appointments for them. If children missed a scheduled appointment, clinic staff called and followed up with the parent to re-schedule the appointment. They also utilized flu clinics to check for other immunizations needed or past due. Warren Clinic Owasso achieved a 100% immunization level in the first quarter of 2013 by focusing on use of the OK BY ONE schedule. The OK BY ONE Schedule simplifies the childhood schedule to 4 visits and is designed to increase the percentage of children who receive the 4th dose of DTaP on time. Use of the OK BY ONE schedule helped clinic staff reduce missed opportunities to vaccinate to zero. The clinic supervisor, Becky Day states, “We were fortunate to have Dr. Chelsea Galutia join our practice last fall. She is a diligent, proactive provider who carefully monitors the vaccination records of her patients. I am confident that her efforts are the reason for this excellent result.” Dr. Thomas Salyer’s Office in Idabel achieved a rate of 84%. Wanda Salyer, office manager, states, “As the office manager I can say that ALL our employees work hard to get the vaccines given on time. Starting with our front office staff, and ending with our nurses. They deserve the recognition. Job well done!” Dr. Salyer’s staff pulls patient charts a week in advance of the appointment to determine what vaccines are due. Charts are reviewed a second time the day before the appointment. If a parent is hesitant about their child receiving immunizations, the nurse explains that by not staying on schedule she will not be able to use combination vaccines to the fullest benefit and this will result in the child receiving more needle sticks overall. Some parents will still not allow more than 2 shots per visit, but with perseverance the clinic staff reached 84% up-to-date. Updated Recommendations for Use of Tdap Vaccine in Pregnant Women Published The Centers for Disease Control and Prevention (CDC) has published updated recommendations for use of Tdap vaccine in pregnant women. These recommendations replace the provisional recommendations posted in October 2012. The Advisory Committee on Immunization Practices (ACIP) recommends that healthcare personnel administer a dose of Tdap to pregnant women during each pregnancy, irrespective of the patient’s prior history of receiving Tdap. To maximize the maternal antibody response and passive antibody transfer to the infant, optimal timing for Tdap administration is between 27 and 36 weeks gestation. However, Tdap may be administered any time during pregnancy. Vaccination of women with Tdap during pregnancy is expected to provide some protection to infants from pertussis until they are old enough to be vaccinated themselves. Provisional pertussis case counts in the U.S. for 2012 surpassed the last peak year, 2010, with 41,880 cases and 14 deaths in infants <12 months of age. In considering whether or not women might receive repeat doses of Tdap during consecutive pregnancies in a short period of time, the ACIP reviewed birth statistics in the U.S. This review revealed that among women with more than one pregnancy, only 2.5% have an interval ≤12 months between births, approximately 5% of women have four or more babies, and for women of lower socioeconomic status, the interval between pregnancies is generally ≥18 months. The ACIP concluded that the interval between most pregnancies is likely longer than the persistence of maternal anti-pertussis antibodies, and most women would receive only 2 Tdap doses and a small proportion would receive ≥4 doses of Tdap.” (MMWR Feb. 22, 2013, Vol. 62, No.7, p. 132). The ACIP also evaluated data on the safety of repeat doses of Tdap in pregnant women and “concluded that experience with tetanus toxoid-containing vaccines suggest no excess risk for severe adverse events for women receiving Tdap with every pregnancy.” (MMWR Feb. 22, 2013, Vol. 62, No. 7, p. 133). Safety monitoring in pregnant women following Tdap administration will include enhanced monitoring of the Vaccine Adverse Event Reporting System (VAERS) and utilization of the Vaccine Safety Datalink (VSD). The recommendations are available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6207a 4.htm?s_cid=mm6207a4_w. For an online version of this Update, visit the Immunization Service web page at: http://www.ok.gov/health/Disease,_Prevention,_Preparedness/Immunizations/Information_for_Health_Professionals/index.html. The OK BY ONE Schedule is available at: http://www.ok.gov/health2/documents/IMM_Parents_OK_BY_ONE_Flyer.pdf
Object Description
Okla State Agency |
Health, Oklahoma State Department of |
Okla Agency Code |
'340' |
Title | Oklahoma immunization update, 03/2013 |
Authors |
Oklahoma. Immunization Service. |
Publication Date | 2013-03 |
Publication type | Newsletter |
Purpose | Oklahoma Clinics Achieve high Immunization Levels; Updated Recommendations for Use of Tdap Vaccine in Pregnant Women Published; |
For all issues click |
H845.6 I33u |
Digital Format | PDF, Adobe Reader required |
ODL electronic copy | Downloaded from agency website: http://www.ok.gov/health2/documents/IMM_Update_2013_March.pdf |
Rights and Permissions | This Oklahoma state government publication is provided for educational purposes under U.S. copyright law. Other usage requires permission of copyright holders. |
Date created | 2013-03-08 |
Date modified | 2013-03-08 |
OCLC number | 829701194 |
Description
Title | IMM_Update_2013_March 1 |
Full text | Oklahoma Immunization Update March 2013 PREVENTION and PREPAREDNESS SERVICES IMMUNIZATION SERVICE PLEASE POST & DISTRIBUTE TO ALL NURSING AND MEDICAL STAFF Oklahoma Clinics Achieve High Immunization Levels The Oklahoma State Department of Health Immunization Service would like to recognize the following clinics for their efforts to increase the immunization levels of children 19 through 35 months of age who have received the primary series of 4 DTaP, 3 polio, 1 MMR, 3 Hib, 3 HepB and 1 varicella: · Indian Health Care Resource Center, Tulsa - 80% · Warren Clinic Owasso - 100% · Dr. Thomas Salyer, D.O., Idabel – 84% The Indian Health Care Resource Center in Tulsa increased their immunization rate from 64% in 2010 to 80% for the first quarter of 2013. This increase was the result of clinic staff calling the parents of children who were behind on their immunizations and scheduling appointments for them. If children missed a scheduled appointment, clinic staff called and followed up with the parent to re-schedule the appointment. They also utilized flu clinics to check for other immunizations needed or past due. Warren Clinic Owasso achieved a 100% immunization level in the first quarter of 2013 by focusing on use of the OK BY ONE schedule. The OK BY ONE Schedule simplifies the childhood schedule to 4 visits and is designed to increase the percentage of children who receive the 4th dose of DTaP on time. Use of the OK BY ONE schedule helped clinic staff reduce missed opportunities to vaccinate to zero. The clinic supervisor, Becky Day states, “We were fortunate to have Dr. Chelsea Galutia join our practice last fall. She is a diligent, proactive provider who carefully monitors the vaccination records of her patients. I am confident that her efforts are the reason for this excellent result.” Dr. Thomas Salyer’s Office in Idabel achieved a rate of 84%. Wanda Salyer, office manager, states, “As the office manager I can say that ALL our employees work hard to get the vaccines given on time. Starting with our front office staff, and ending with our nurses. They deserve the recognition. Job well done!” Dr. Salyer’s staff pulls patient charts a week in advance of the appointment to determine what vaccines are due. Charts are reviewed a second time the day before the appointment. If a parent is hesitant about their child receiving immunizations, the nurse explains that by not staying on schedule she will not be able to use combination vaccines to the fullest benefit and this will result in the child receiving more needle sticks overall. Some parents will still not allow more than 2 shots per visit, but with perseverance the clinic staff reached 84% up-to-date. Updated Recommendations for Use of Tdap Vaccine in Pregnant Women Published The Centers for Disease Control and Prevention (CDC) has published updated recommendations for use of Tdap vaccine in pregnant women. These recommendations replace the provisional recommendations posted in October 2012. The Advisory Committee on Immunization Practices (ACIP) recommends that healthcare personnel administer a dose of Tdap to pregnant women during each pregnancy, irrespective of the patient’s prior history of receiving Tdap. To maximize the maternal antibody response and passive antibody transfer to the infant, optimal timing for Tdap administration is between 27 and 36 weeks gestation. However, Tdap may be administered any time during pregnancy. Vaccination of women with Tdap during pregnancy is expected to provide some protection to infants from pertussis until they are old enough to be vaccinated themselves. Provisional pertussis case counts in the U.S. for 2012 surpassed the last peak year, 2010, with 41,880 cases and 14 deaths in infants <12 months of age. In considering whether or not women might receive repeat doses of Tdap during consecutive pregnancies in a short period of time, the ACIP reviewed birth statistics in the U.S. This review revealed that among women with more than one pregnancy, only 2.5% have an interval ≤12 months between births, approximately 5% of women have four or more babies, and for women of lower socioeconomic status, the interval between pregnancies is generally ≥18 months. The ACIP concluded that the interval between most pregnancies is likely longer than the persistence of maternal anti-pertussis antibodies, and most women would receive only 2 Tdap doses and a small proportion would receive ≥4 doses of Tdap.” (MMWR Feb. 22, 2013, Vol. 62, No.7, p. 132). The ACIP also evaluated data on the safety of repeat doses of Tdap in pregnant women and “concluded that experience with tetanus toxoid-containing vaccines suggest no excess risk for severe adverse events for women receiving Tdap with every pregnancy.” (MMWR Feb. 22, 2013, Vol. 62, No. 7, p. 133). Safety monitoring in pregnant women following Tdap administration will include enhanced monitoring of the Vaccine Adverse Event Reporting System (VAERS) and utilization of the Vaccine Safety Datalink (VSD). The recommendations are available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6207a 4.htm?s_cid=mm6207a4_w. For an online version of this Update, visit the Immunization Service web page at: http://www.ok.gov/health/Disease,_Prevention,_Preparedness/Immunizations/Information_for_Health_Professionals/index.html. The OK BY ONE Schedule is available at: http://www.ok.gov/health2/documents/IMM_Parents_OK_BY_ONE_Flyer.pdf |
Date created | 2013-03-08 |
Date modified | 2013-03-08 |